Sökning: onr:"swepub:oai:gup.ub.gu.se/60279" >
Growth hormone redu...
-
Franco Ramos, Celina,1956Gothenburg University,Göteborgs universitet,Institutionen för medicin, avdelningen för invärtesmedicin,Institute of Medicine, Department of Internal Medicine
(författare)
Growth hormone reduces inflammation in postmenopausal women with abdominal obesity: a 12-month, randomized, placebo-controlled trial.
- Artikel/kapitelEngelska2007
Förlag, utgivningsår, omfång ...
-
The Endocrine Society,2007
Nummerbeteckningar
-
LIBRIS-ID:oai:gup.ub.gu.se/60279
-
https://gup.ub.gu.se/publication/60279URI
-
https://doi.org/10.1210/jc.2007-0068DOI
Kompletterande språkuppgifter
Ingår i deldatabas
Klassifikation
-
Ämneskategori:ref swepub-contenttype
-
Ämneskategori:art swepub-publicationtype
Anmärkningar
-
CONTEXT: Abdominal obesity is associated with low GH secretion, elevated circulating markers of inflammation, and increased risk of cardiovascular disease. OBJECTIVE: The objective was to study the effect of GH treatment on inflammatory markers and vascular adhesion molecules in postmenopausal women with abdominal obesity. DESIGN: Forty women aged 51-63 yr received GH (0.67 mg/d) in a randomized, double-blind, placebo-controlled, 12-month trial. Measurements of inflammatory markers [highly sensitive C-reactive protein (CRP), IL-6, and amyloid polypeptideA] and markers of endothelial dysfunction (soluble E-selectin, vascular adhesion molecule-1, intercellular molecule-1, and matrix metalloproteinase-9) were performed at baseline and after 6 and 12 months of treatment. RESULTS: After 12 months, the mean IGF sd score was 0.9 +/- 1.5 and -0.8 +/- 0.6 in the GH and placebo groups, respectively. GH treatment reduced CRP and IL-6 levels compared with placebo (P = 0.03 and P = 0.05, respectively), whereas the markers of endothelial dysfunction were unaffected. Within the GH-treated group, a reduction was shown in CRP (4.3 +/- 4 to 3.0 +/- 3 mg/liter; P < 0.05) and in IL-6 (4.4 +/- 2 to 3.3 +/- 2 ng/liter; P < 0.01). In the GH-treated group, the decrease in CRP and IL-6 correlated with a reduction in visceral adipose tissue (r = 0.7, P < 0.001 and r = 0.5, P < 0.05, respectively). CONCLUSION: GH treatment in postmenopausal women with abdominal obesity reduced serum markers of systemic inflammation. Circulating markers of endothelial dysfunction were unaffected by treatment.
Ämnesord och genrebeteckningar
-
Abdominal Fat
-
Aged
-
C-Reactive Protein
-
metabolism
-
Endothelium
-
Vascular
-
drug effects
-
immunology
-
Female
-
Human Growth Hormone
-
therapeutic use
-
Humans
-
Inflammation
-
blood
-
drug therapy
-
Interleukin-6
-
blood
-
Middle Aged
-
Obesity
-
drug therapy
-
immunology
-
metabolism
-
Placebos
-
Postmenopause
-
Serum Amyloid A Protein
-
metabolism
Biuppslag (personer, institutioner, konferenser, titlar ...)
-
Andersson, Björn,1953Gothenburg University,Göteborgs universitet,Institutionen för medicin,Institute of Medicine(Swepub:gu)xandeb
(författare)
-
Lönn, Lars,1956Gothenburg University,Göteborgs universitet,Institutionen för kliniska vetenskaper,Institute of Clinical Sciences(Swepub:gu)xlonla
(författare)
-
Bengtsson, Bengt-Åke,1944Gothenburg University,Göteborgs universitet,Institutionen för medicin,Institute of Medicine(Swepub:gu)xbenbe
(författare)
-
Svensson, Johan,1964Gothenburg University,Göteborgs universitet,Institutionen för medicin,Institute of Medicine(Swepub:gu)xsjohc
(författare)
-
Johannsson, Gudmundur,1960Gothenburg University,Göteborgs universitet,Institutionen för medicin,Institute of Medicine(Swepub:gu)xjgudn
(författare)
-
Göteborgs universitetInstitutionen för medicin, avdelningen för invärtesmedicin
(creator_code:org_t)
Sammanhörande titlar
-
Ingår i:The Journal of clinical endocrinology and metabolism: The Endocrine Society92:7, s. 2644-70021-972X1945-7197
Internetlänk
Hitta via bibliotek
Till lärosätets databas